Regulatory testing and commercial validation are not the same thing
Field work before pesticide registration serves two different purposes. One is regulatory: generating evidence required under the applicable Indonesian registration framework. The other is commercial: proving that the product can outperform, differentiate or fit into a real Indonesian crop-protection program. That commercial evidence should feed directly into the Indonesia market-opportunity assessment and later into the field-validation-to-launch pathway.
Both matter, but they should not be confused. A compliant study may support registration while still leaving unanswered questions about farmer value, competitive positioning, price tolerance or the best launch geography.
The Ministry of Agriculture publishes current pesticide registration rules, technical criteria and recognised testing references through its official pesticide regulation portal. These should be checked before any protocol is finalised.
What should be defined before the first trial
- Target crop and pest — the problem must be specific enough to support a meaningful protocol.
- Intended claim — field evidence should match the use pattern the principal expects to register and commercialise.
- Comparator — the benchmark should reflect the mainstream product, mode of action or farmer practice the new product must beat or complement.
- Measurement — define efficacy, crop safety, persistence, yield or other relevant outcomes before the trial starts.
- Site relevance — the trial should be located where the target problem is commercially meaningful, not merely where land is available.
Why comparison trials are commercially important
A principal may know that its product works. The harder question is whether Indonesian retailers and farmers will see enough difference to switch, add the product or pay the intended price. This is why RAI favours comparison trials against credible market standards where appropriate.
Useful commercial evidence can include speed of control, residual activity, crop safety, consistency across sites, fit with farmer spray programs and the strength of the response under realistic pest pressure. The result should help answer a business question, not simply create another data point.
How field evidence should influence registration investment
Strong local evidence can improve decisions on priority crops, claims, pack sizes, price corridors and launch geographies. Weak or inconsistent evidence may justify changing the protocol, repositioning the product or stopping the project before more registration capital is committed.
This is why registration feasibility should start with market evidence rather than a submission calendar alone.
A practical evidence ladder
- Screen: confirm the product has a credible crop–pest opportunity.
- Benchmark: compare against the current market standard.
- Validate: repeat under relevant local conditions and measure consistency.
- Translate: convert results into a compliant technical and commercial value proposition.
- Scale: use the evidence to design demos, retailer education and launch priorities.
Related RAI resources
Explore RAI’s field evidence and market-validation capability, review Indonesia crop–pest–province opportunity mapping, or discuss a field-validation brief.
This article is strategic information and does not replace current technical or regulatory advice.